Article Text

Download PDFPDF
Basics of cardiac pacing: selection and mode choice
  1. John M Morgan
  1. Correspondence to:
    Dr John M Morgan
    Wessex Cardiology, Cardiology Offices, Tremona Road, Southampton SO16 6UY, UK; jmm{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Therapeutic cardiac stimulation has been in clinical practice for many decades.1 During the evolution of the therapy, pacing generators have shrunk in size, increased in longevity, and increased in device complexity. They offer rhythm and disease state diagnostics, with various algorithms designed to offer timing of delivery of pacing impulse and more recently diagnostics indicative of pathophysiology. Pacing leads have also reduced in size and improved in durability. Pacing electrode configurations have enhanced sensing capability and stability of long term pacing function.

With the potential for a range of biosensors that could be incorporated in pacemaker devices to further the potential for pathophysiological monitoring, cardiac pacing has achieved an extraordinary maturity in the armoury of cardiac treatments. However, it has taken much longer for there to be large scale clinical trials on the therapeutic efficacy of devices, long term patient well being, and the impact of right ventricular pacing on left ventricular function.


These are summarised in published European and North American guidelines.2,3 There are three electrophysiological conditions (sinus node disease, atrioventricular (AV) node disease, and neurally-mediated (cardio-inhibitory) syncope) which may cause either prognostically or symptomatically significant bradycardia, and this review focuses only on these. These conditions may be treated by single chamber ventricular sensing/pacing, dual chamber sensing/pacing or (if AV nodal function is normal) single chamber atrial sensing/pacing.

The choice of appropriate pacing modality to treat these electrophysiological abnormalities is governed by our understanding of the morbidity that attends the conditions themselves, the influence of pacing on that morbidity, and a further morbidity that may attend the chosen pacing mode. To understand this complex interaction we need to look to the evidence base that reports efficacy and complications of pacing therapy in varying patient populations with differing electrophysiological and cardiac disease.


This article focuses on six …

View Full Text


  • In compliance with EBAC/EACCME guidelines, all authors participating in Education in Heart have disclosed potential conflicts of interest that might cause a bias in the article

Linked Articles

  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society